{
  "pmcid": "12112255",
  "sha256": "f7b5d413e50239a3e0b5c4e9620863b04ad214cbe428e77e8cddc899f100a249",
  "timestamp_utc": "2025-11-09T23:26:57.284126+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.488636363636363,
    "reading_ease": 37.675454545454556,
    "word_count": 440
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of the Alfalfa App for Warfarin Management in Post-Cardiac Valve Replacement Patients"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised 1:1 using a Microsoft Excel-generated list."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were eligible if they had been on warfarin for at least 3 months, received warfarin management through the Alfalfa app or pharmacist-led clinic visits, and had no serious bleeding or thrombotic events in the prior 3 months."
      },
      "Intervention": {
        "score": 2,
        "evidence": "received warfarin management through the Alfalfa app or pharmacist-led clinic visits"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy, safety, and cost-effectiveness of the Alfalfa app for warfarin management compared to offline methods."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the time in therapeutic range (TTR) over 3 months."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomised 1:1 using a Microsoft Excel-generated list."
      },
      "Blinding": {
        "score": 1,
        "evidence": "The study was open-label."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 405 participants were analysed (204 in the Alfalfa group, 201 in the offline group)."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 405 participants were analysed (204 in the Alfalfa group, 201 in the offline group)."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The Alfalfa group had a higher TTR (66.46% vs 46.65%, P <.001) and monitoring frequency (8.14 vs 4.47, P <.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Minor bleeding was more frequent in the Alfalfa group (5.9% vs 1.5%, P =.02)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR1900021920."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}